See also this year's filing and all EDGAR filings for this company.
PDF Report 0001509190_2019_Aratana_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001509190, Aratana Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 58,127,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 46,945,000 |
| 2 | PropertyPlantAndEquipmentNet | 693,000 |
| 3 | remainder_Assets | 671,000 |
| 4 | LiabilitiesCurrent | 5,557,000 |
| 5 | LiabilitiesNoncurrent | 57,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 6,783,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 28,758,608 |
| 9 | ResearchAndDevelopmentExpense | 4,975,632 |
| 10 | remainder_Expenses | 14,317,038 |
| 11 | remainder_Revenues | 32,635,363 |
| 12 | remainder_NetIncome | -2,872,136 |
| 13 | remainder_ComprehensiveNetIncome | -757,919 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 106,436,000 |
| 1 | Liabilities | 5,614,000 |
| 2 | Expenses | 54,834,278 |
| 3 | Revenues | 32,635,363 |
| 4 | StockholdersEquity | 100,822,000 |
| 5 | NetIncome | -25,071,051 |
| 6 | ComprehensiveNetIncome | -25,450,010 |
| 7 | BaseVar | 101,574,848 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.47 |
| 9 | EconomicCapitalRatio | 4.01 |
Edgar->Model Mapping
Feature Distribution
Change over Time
